Resumen
A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 376-377 |
Número de páginas | 2 |
Publicación | The Lancet |
Volumen | 355 |
N.º | 9201 |
DOI | |
Estado | Published - ene. 29 2000 |
Publicado de forma externa | Sí |
ASJC Scopus Subject Areas
- General Medicine
PubMed: MeSH publication types
- Clinical Trial
- Letter